Mood Disorders Research at Sheppard Pratt
Why we Study Mood Disorders
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident, sunt in culpa qui officia deserunt mollit anim id est laborum.
Current Studies and Clinical Trials
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut a
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut a
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut a
Featured Researchers
-
Scott Aaronson, MD
Chief Science Officer, Institute for Advanced Diagnostics and TherapeuticsSpecialties:Adult Psychiatry, Biological Psychiatry, Depression, Medication Management, Mood Disorders, Psychopharmacology, Transcranial Magnetic Stimulation (TMS), Treatment-resistant Depression -
Faith Dickerson, PhD, MPH
Director of Psychology, Research, and EducationSpecialties:Schizophrenia, Psychotic Disorders, Severe Mental Illness
Recent Discoveries
New Study Conducted at Sheppard Pratt Finds Psilocybin-Assisted Therapy May Reduce Chronic Suicidal Ideation
The Journal of Clinical Psychiatry recently published results from a clinical trial conducted at Sheppard Pratt, examining the efficacy and safety of psilocybin-assisted…